Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health carelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M)
Annual figures from Elevance Health's filings and investor materials
Latest, FY2025
40,077
Period ended Dec 31, 2025
Change on a year earlier
+21.5%
32,978 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40,077 | +21.5% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2024 | Dec 31, 2024 | 32,978 | +4.4% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 31,588 | +19.0% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 26,544 | – | 10-K (FY2024, 2025-02-20) ↗ |
Cite this data
StockData. (2026). Elevance Health CarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M), annual FY2022–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_carelonrx_cost_of_products
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.